Bioelectric Medicine Market Size, Share Report 2020 Shipments, Price, Revenue and Gross profit till 2025 With Impact of COVID-19

The MarketWatch News Department was not involved in the creation of this content.

Dec 03, 2020 (The Expresswire) —
“Final Report will add the analysis of the impact of COVID-19 on this industry.”

“Bioelectric Medicine Market” research report offers the breakdown of the industry by market size, rate of development, key companies, counties, product selections and application. The Bioelectric Medicine Market Report delivers current state, openings, limits, drivers and also the evolution forecasts of the market by 2025. Profound investigation about Bioelectric Medicine market standing, enterprise competition outline, welfares and drawbacks of enterprise stock, Bioelectric Medicine industry development trends, regional industrial layout features and economics policies, industry News and Strategies by Regions has additionally been enclosed.

Get a Sample Copy of the Report at-

In Regional Analysis, the Bioelectric Medicine market is also categorised into North America, Europe, China, Japan, the middle East, India, South America, Others. North America, Europe is expected to account for a distinguished share, in terms of price and extent, of the Bioelectric Medicine market throughout the forecast length. The Bioelectric Medicine market within the Asia Pacific is projected to extend throughout the forecast period. Evolving markets that include China and Asian country are expected to play a significant position within the boom in producing the surrounding area.

Years considered for this report:

Historical Years: 2015-2019

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2020-2025

To Understand the Impact of COVID-19 on Bioelectric Medicine Market: –

Bioelectric Medicine market report provides in-depth data about company Profiles, Bioelectric Medicine launching and Market Positioning, their Production, Value, Price, ratio and Target Customers. Research report contains data about following major players in Bioelectric Medicine market, which strategically profile the key players and comprehensively analyse their growth strategies and market segmentation:

Key players in the global Bioelectric Medicine market covered in report:

● Nevro ● Second Sight Medical Products ● Sonova Holding ● St. Jude Medical ● Medtronic ● Cochlear ● Electrocore ● Boston Scientific Corporation ● Livanova ● Biotronik

On the basis of types, the Bioelectric Medicine market from 2015 to 2025 is primarily split into:

● Implantable Cardioverter Defibrillators ● Cardiac Pacemakers ● Spinal Cord Stimulators ● Cochlear Implants ● Deep Brain Stimulators ● Transcutaneous Electrical Nerve Stimulators ● Vagus Nerve Stimulators ● Sacral Nerve Stimulators ● Retinal Implants ● Other Electrical Stimulators

On the basis of applications, the Bioelectric Medicine market from 2015 to 2025 covers:

● Hospitals ● Research Institutes ● Individual Users

Inquire or Share Your Questions If Any Before the Purchasing This Report-

Bioelectric Medicine Market Report Scope:

The In-depth industry chain includes analysis value chain analysis, porter five forces model analysis and cost structure analysis. This Bioelectric Medicine Market report describes present situation, historical background and future forecast. It Comprehensive data showing Bioelectric Medicine sale, consumption, trade statistics, and prices in the recent years are provided. The Bioelectric Medicine report indicates a wealth of information on Bioelectric Medicine vendors. Bioelectric Medicine Market forecast for next five years, including Market volumes

Read More

Fitness Keto Reviews (Scam or Legit): Pills Price & Ingredients

New York, 10016 ( TS Newswire ) — 13 Nov 2020

Fitness has become like a precious gem in the current times. With the growing pandemic situation around the globe, every person is concerned about its health. Today, people are trying different methods to stay fit and healthy. They go on diet and consume healthy drinks to gain more energy. Besides, they also visit gyms and do workouts at homes for weight loss.


Normal weight loss techniques cannot give guaranteed results. One needs to try a lot more along with dieting and health drinks.

Fitness Keto is a dietary supplement for people who want to gain a perfect figure. It is a natural product for weight loss and curing many other health disorders that people face daily.

How it is developed?

Most of the health drinks, protein powders, and dietary supplements today contain artificial preservatives. But Fitness Keto is a natural product. It is prepared from BHB. Beta-hydroxybutyrate is widely used in the making of weight loss products. It also starts the metabolism process in the body speedily.

This weight loss formula may contain plant and herb extracts. It may not contain:

– Artificial preservatives

– Colors

– Flavors

– Soy

– Gluten

– Sweeteners or other toxic substances

Each element is tested in the labs before making the Fitness Keto diet pill. Because of natural composition, this product may not give side effects in the body such as headaches, migraines, and vomiting.

One may use Fitness Keto even for a long time. It is suitable for both young and old people. Furthermore, the manufacturing process of this product takes place in clean conditions.


Benefits of using Fitness Keto

Fitness Keto pill is an organic formula for weight loss. It helps the body in various ways such as:

– Slim body

Fitness Keto may burn extra fats from the belly, cheeks, thighs, muscles, and hips. It may stop fats to accumulate again in those areas. Within a few weeks, one may get a slim figure and more confidence. One may get an attractive figure free of fats with Fitness Keto.

– Better mental health

One may get a better mental focus after using Fitness Keto advanced weight loss formula. This natural weight loss formula may help in gaining high levels of concentration. One may get more attentive in the work and studies after taking this natural formula. It may also make memory better and sharper.

– Active day

Normal weight loss products work by burning carbohydrates of the body. But Fitness Keto supplement may burn fats of the body. As fats are good sources of energy, one may get more active after consuming this weight loss product. It may help to recover from gym workouts and exercises.

– Controls hunger

Fitness Keto may control appetite and hunger as well. It may give full feeling in the stomach. One may not feel

Read More

Amazon Black Friday Fitbit Charge 4 deal takes fitness tracker to its lowest EVER price BY FAR!

Fitbit Charge 4 Special Edition is the best fitness tracker this market-leading brand makes. It’s always good value at under £130/$150, but this deal takes it down to a crazy low price. It’s unlikely it will get much cheaper than that, even when the best Black Friday deals are unveiled at the end of November.

• Buy Fitbit Charge at for just $99.99 – was $149.99 so you save a massive $50!

In the UK? Don’t feel too left out. 

• Buy Fitbit Charge 4 for £119.99 (£10 off RRP).

Okay so that ain’t so great. 

The American deal is absolutely exceptional, however. It’s not just the cheapest this GPS-enabled fitness band with enhanced heart-rate tracking, VO2 Max estimates, super-advanced sleep tracking has ever been. It is the cheapest it has ever been by a HUGE distance.

Dive in now America, this deal will end in 5, 4, 3, 2… 

Charge 4 deal in the USA

Today’s best Fitbit Charge 4 deals

Fitbit Charge 4 Fitness and…

Fitbit – Charge 4 Activity…

Fitbit Charge 4 – black -…

Charge 4 deal in the UK

Today’s best Fitbit Charge 4 deals

Fitbit Charge 4 Fitness and…

Fitbit – Charge 4 Activity…

Fitbit Charge 4 – black -…

Why should you buy the Fitbit Charge 4 

Fitbit Charge 4

(Image credit: Fitbit)

Unlike its predecessor, Fitbit Charge 4 comes with built-in GPS so you can track your activities more precisely without needing to have your phone on you all the time. Should you want to have your phone on you, you can also use the Fitbit Charge 4 to control Spotify from your wrist.

The improved Active Zone Minutes system tracks your overall activity levels. This means it scores you higher for intense exercise than for going for a quick 200 steps around the neighborhood. This can give you a much better understanding of just how ‘active’ you were during the day/week and prioritises exercise that really elevates your heart rate. 

Less strenuous activities are also tracked of course if you’re more focussed on doing your 10,000 steps per day.

The Fitbit Charge 4 has a battery life of ‘up to’ 7 days – dependent on GPS usage – and you can pay in shops with it thanks to the Fitbit Pay feature. This water resistant fitness tracker monitors your heart rate 24/7, counts calorie burned, and has 15+ pre-loaded exercise profiles. You can track your goals all day, then have it monitor and rate your sleep at night.

It also utilises the excellent Fitbit App, where you can further scrutinise your fitness

Read More

Timex launches first fashion fitness band in India, price starts at Rs 4495

a close up of a watch

Watch manufacturer Timex had unveiled its new range of fitness bands in India. The company on Tuesday released its first fashion fitness band. Timex had previously rolled out many fitness bands and smartwatches in the budget segment but this time it has taken cognizance of the style-conscious buyers. The new range of fitness bands by Timex comes with a stainless steel mesh band as well as a silicone strap.

Talking about the launch of fitness bands by Timex, Ajay Dhyani, Head- Marketing and E-Commerce, Timex Group said, “We are thrilled to announce the launch of our first-ever fitness band in India. At Timex, we always strive to bring cutting edge technology to our customers at a relatively affordable price. This fitness band is the latest example where we are pushing the boundaries of innovation and providing Indian consumers the opportunity to own high-quality band which they can wear anytime- whether it is a formal get-together, a business meeting, or any outdoor activity.”

Timex has launched the fashion fitness bands in India for Rs 4495 and can be ordered from the official website of Timex. It is also available at selected Timex retail stores. It might go on sale on the e-commerce platforms including Amazon and Flipkart too but Timex is yet to confirm that.

Now coming to some of the important features of the fitness band. At Rs 4495, the first thing that would attract the buyers is its stainless steel mesh band over the silicon straps. All the companies that are selling fitness bands have used silicon straps but Timex brings a lot of newness to the platter by introducing fitness bands with a stainless steel mesh band. The band is available in two interesting colors to choose from including the Rose Gold color and the black color.

As far as the specs are concerned, the Timex fitness band comes with a 2.4 cm colored full touch display. It comes with features including activity tracking, music control, heart rate monitor, and notification alert. The company claims that the watch comes with a battery back up of 5 days.

Timex is one of the oldest watch manufacturers in India and with its latest fitness band, the company has retained the old world charm with the latest technology. The company had earlier launched smart bands and smartwatches under the helix brand.

Source Article

Read More

Lebanon patients ‘pay price of bad governance’ in medicine shortages

Mohamad Zarif scoured about 20 Beirut pharmacies looking for prescription medicine for his mother’s arthritis, so painful that it left her “screaming and crying”. Yet every pharmacy was out of stock. His frantic search finally reached war-torn Syria, where a contact bought Iranian-produced versions of the drugs and sent them to him.

The 29-year-old is not alone: the struggle faced by Lebanese patients in acquiring vital medicines starkly illustrates the severity of the economic crisis. Cancer patients battle to find medication, patients’ friends and family import drugs in suitcases and some pharmacists bemoan a lack of basic supplies such as Panadol.

In recent weeks, the health ministry has asked pharmacists to limit the quantity of drugs they sell to customers in an effort to stem panic buying, triggered by a central bank warning on an expected shortage of hard currency for vital imports, including medicine, by year’s end. Patients and wholesalers subsequently stockpiled medicines, contributing to widespread shortages.

“We asked [pharmacists] to sell only one box per person,” the health ministry said. It added that the authorities were forcing some importers that had stockpiled medicines to send the goods to pharmacists.

The shortages come as Lebanon endures its worst economic crisis in 30 years, grappling with a plunging currency, hyperinflation and soaring unemployment and poverty. It is also blighted by political paralysis as rival parties fail to agree on forming a new government, more than two months after the prime minister resigned after an explosion at Beirut’s port killed at least 190 people.

Goldman Sachs estimated in September that gross hard currency reserves were down to $20bn by August, and falling by $2bn a month. The investment bank said the reserves could be exhausted within 12 months without remedial action.

As the central bank struggles to protect its diminishing reserves, it has prioritised allocating dollars at an official exchange rate to importers in sectors such as medicine, fuel and food. The measure is supposed to protect essential goods from soaring inflation.

After the warning by central bank governor Riad Salame that triggered the panic buying, Naaman Naddour, the director responsible for subsidies at the bank, told the Financial Times he could not predict how long it could keep up its support for imports.

He said the institution had already allocated $1bn for medicine imports so far in 2020, rejecting complaints from importers that obtaining dollars was slow and impeding their ability to bring in the medicines.

“The stock levels we have are limited and not made to cover this kind of high demand,” said Karim Gebara, head of the pharmaceutical importers syndicate, explaining why the panic buying stripped shelves. “Demand was three times higher than normal.”

Lebanon imports most of its medicine from countries such as Germany. But now Lebanese flying into Beirut bring suitcases crammed with treatments for friends and family, say patients and their informal medicine mules, as doctors advise patients to look for alternatives to their

Read More

This Black Friday Fitbit Charge 4 deal at Amazon takes fitness tracker to its lowest ever price

Fitbit Charge 4 Special Edition is the best fitness tracker this market-leading brand makes. It’s always good value at under £150, but this deal takes it down to just £130 for one day only. It’s unlikely it will get much cheaper than that, even when the best Black Friday deals are unveiled at the end of November.

• Buy Fitbit Charge 4 Special Edition at Amazon, on sale for £129.99 – was £149.99, so you save £20 at Amazon

The Charge 4 Special Edition is functionally identical to the excellent Charge 4 but has a more premium finish. If you want a standard Charge 4, that is also discounted today and can be bought for £119.99 (£10 off RRP).

Fitbit Charge 4 Special Edition £129.99 | Was £149.99 | Save £20 at Amazon
The Fitbit Charge 4 Special Edition has all the features of the standard edition, but is made from more premium materials and boasts a nicer strap. It tracks heart rate 24/7, estimates your calories burned and monitors sleep. Unlike most older, lesser Fitbits it has GPS built in to track runs, hikes and bike rides, plus a blood oxygen sensor to track… blood oxygen. Deal ends today.View Deal

Today’s best Fitbit Charge 4 deals

Fitbit Charge 4 Fitness and…

Fitbit Charge 4 Fitness and…

Fitbit Charge 4 Fitness…

Fitbit Charge 4 Granite…

Why should you buy the Fitbit Charge 4 

Unlike its predecessor, the Fitbit Charge 4 comes with built-in GPS so you can track your activities more precisely without needing to have your phone on you all the time. Should you want to have your phone on you, you can also use the Fitbit Charge 4 to control Spotify from your wrist.

The improved Active Zone Minutes system tracks your activity levels even when you are not using a sport mode on the fitness tracker. This can give you a better understanding of just how ‘active’ you were during the day/week and prioritises exercise that really elevates your heart rate. Less strenuous activities are also tracked of course if you’re more focussed on doing your 10,000 steps per day.

The Fitbit Charge 4 has a battery life of ‘up to’ 7 days – dependent on GPS usage – and you can pay in shops with it thanks to the Fitbit Pay feature. This water resistant fitness tracker monitors your heart rate 24/7, counts calorie burned, and has 15+ pre-loaded exercise profiles. You can track your goals all day, then have it monitor and rate your sleep at night.

It also utilises the excellent Fitbit App, where you can further scrutinise your fitness and weight loss progress using easy-to-understand charts and graphs. Smartwatch-style notifications are also included.

Yet more Fitbit deals

Read More

HHS Finalizes Rule on Insurer Price Transparency

WASHINGTON — Private health insurers will have to start posting their prices publicly within the next several years according to a final rule issued Thursday by the Department of Health and Human Services (HHS).

“This shadowy system” of healthcare pricing “has to change; the patient has to be in control,” HHS Secretary Alex Azar said on a phone call with reporters. “That means giving them the right to know what they’re going to owe for a healthcare service before they ever get it.” Right now, however, “patients don’t have the information they need to shop around and get a good deal … and have an informed conversation with their doctor about what makes sense for them.”

The final rule — which was issued by HHS together with the Labor and Treasury departments — would require almost all private health insurance plans to give the 200 million Americans they cover real-time access to information about negotiated prices and cost-sharing, beginning with a list of the 500 most “shoppable” services in 2023, Azar said. This list would be expanded to include all healthcare services in 2024. “This is information that patients typically receive after they get those services, through an EOB [Explanation of Benefits] form,” but now they could get it ahead of time.

Through a shopping tool available through their plan or insurance company, consumers will be able to see the negotiated rate between their doctor and their plan or insurer, as well as the most accurate out-of-pocket cost estimate possible based on their health plan for procedures, drugs, durable medical equipment, and any other item or service they may need, HHS said in a press release. “Consumers will also have access to accurate price and plan information that allows them to shop and compare costs between individual doctors before receiving care, so they can choose a healthcare provider that offers the most value and best suits their medical needs.”

In 2022, a year before the real-time access provision takes effect, insurers will be required to publish their negotiated rates in data files that will be searchable by patients, employers, researchers, and app developers who could then develop tools to help patients choose their providers. “The vast majority of patients don’t have easy access to this information today,” said Azar.

“In one study when prices for imaging were made transparent, the prices dropped almost 20%,” he said. “You should have the right to know what a healthcare service is going to cost, and the right to know what it’s going to cost you out-of-pocket. That’s what today’s rule will do.”

For each insurer, three data files will be available: one with prices for in-network providers and services, one with prices for out-of-network providers and services, and another for in-network prices for all prescription drugs.

HHS giving insurers a lot of time to comply with the new rule “reflects that there’s a lot of work involved, but that work is only necessary because entrenched special interests in the healthcare system have for

Read More

Possible coronavirus exposures at Madison County Walmart, Price Chopper, Planet Fitness

Oneida, N.Y. — The Madison County Health Department is warning of three potential recent exposures to the coronavirus.

Health officials said that anyone who visited the following locations during the following times should monitor for symptoms:

Planet Fitness, 2002 Glenwood Shopping Plaza, Oneida. Time of exposure: Oct. 20, from 5 p.m. to 5:45 p.m.; and Oct. 21 and 22, from 5 to 5:15 p.m.

Walmart, 2024 Genesee St., Oneida. Time of exposure: Oct. 22, from 5:30 to 5:45 p.m.

Price Chopper, 142 Genesee St, Oneida. Time of exposure: Oct. 21, from 5:30 to 5:45 p.m.

In all three cases, the individuals who tested positive for Covid-19 who visited the three locations were wearing masks.

The county encourages anyone who visited those locations to monitor themselves for symptoms of Covid-19, which include fever, cough, chills, muscle pain, sore throat, new loss of taste or smell, congestion or runny rose, nausea and vomiting, diarrhea or difficulty breathing. County officials say anyone who visited Walmart and Planet Fitness in Oneida should monitor for symptoms through Nov. 5; and anyone who was at Price Chopper should monitor through Nov. 4.

“It is important that residents remain diligent and continue to do their part to limit the spread of COVID-19,” county health officials said in a news release. “Please protect yourself and others by wearing a face covering when you are out in public, especially when you are unable to maintain social distancing. Also, please practice good hygiene. These guidelines are for all of our protection to stop the spread of COVID-19 in our community.”

Madison County also announced it has partnered with SUNY Upstate to hold Covid-19 diagnostic mobile testing clinics.

Testing is available to anyone interested at no cost to the patient, however they are by appointment only. To schedule an appoint, call (315) 464-2582 and select option 0.

“They are experiencing longer than usual wait times, so please be patient and remain on hold to book an appointment,” health officials said.

The mobile testing clinics are scheduled from 3 to 7 p.m. on the following Thursdays:

Oct. 29 and Nov. 12 at the Madison County Complex parking lot, 138 N. Court St., Wampsville.

Nov. 5 at the Hamilton Village Police Department, 5121 Wings Way, Hamilton.

For more information and a full list of potential exposures, visit the Madison County Health Department website.

Have a tip or a story idea? Contact Catie O’Toole: [email protected]  5/8 text/call 315-470-2134 5/8  Twitter  5/8  Facebook


©2020 Syracuse Media Group, N.Y.

Visit Syracuse Media Group, N.Y. at

Distributed by Tribune Content Agency, LLC.

Continue Reading

Source Article

Read More

Lost cures and innovation, too high a price for Democrats’ drug pricing proposals

Democrats and Republicans alike can agree on one thing: prescription drug prices are unacceptably high. Predictably, however, we cannot seem to agree on a proper solution to this urgent issue.

The Trump administration has, thankfully, kickstarted efforts and approved record numbers of generic drugs while simultaneously lowering overall prescription drug prices by 13 percent. It is our responsibility in Congress to keep this momentum going and establish permanent fixes to the current pharmaceutical pricing standards. Despite the efforts of Republicans to make bipartisan progress to reform the prescription drug standards, our Democrat colleagues refuse to collaborate.

Unfortunately, the so-called “solutions” my Democrat colleagues have presented are inadequate and misguided. Their primary proposal, H.R. 3, The Elijah E. Cummings Lower Drug Costs Now Act, is not only an egregious government overreach, but would negatively affect seniors by expanding entitlements and disregarding the Medicare trust fund. This could risk the ultimate failure of the entire program and almost certainly increase out-of-pocket costs for our seniors.

Perhaps most concerningly, it would strangle innovation among the pharmaceutical industry and therefore prevent potential cures. The Congressional Budget Office (CBO) predicts that H.R. 3 would likely result in 38 fewer cures over the next 20 years. For an American waiting for a cure to save their life, this is unacceptable.

That is why the Republicans presented H.R.19, the Lower Cost, More Cures Act, a common-sense and inclusive drug pricing proposal. H.R. 19 sought to incentivize competition in the market to drive prices down and expand market access for more generic and biosimilar drugs. Despite the fact that each of the individual provisions included within H.R.19 were originally bipartisan bills, this legislation has not been spared the classic politicization of Speaker Nancy PelosiNancy PelosiBrown says Biden’s first moves as president should be COVID relief, voting rights Sunday shows – Spotlight shifts to positive tests among Pence aides Pelosi dismisses talk of White House compromise on stimulus: They ‘keep moving the goal post’ MORE (D-Calif.) and has failed to receive proper consideration on the House floor.

Specifically, this legislation contained more than 40 bipartisan provisions that would have been able to go to the president’s desk immediately to be signed into law and help our families. For drug pricing, it provided language for increased pricing transparency, public disclosure of drug discounts, a study of pharmaceutical supply chain intermediaries and merger activity and makes prescription drug marketing sample information reports available to individuals.

With over 3.5 million of my fellow Floridians enrolled in some form of Medicare prescription drug coverage, these issues have always been a top priority. For Medicare Part B, H.R. 19 would have provided increased pricing transparency by expanding a Medicare online tool to allow beneficiaries to compare costs. Additionally, the legislation would have also created maximum add-on payments for certain drugs and biologicals to help reduce out-of-pocket costs.

My constituents and countless Americans who depend on life-saving prescriptions everyday deserve better than the inadequate solutions that my Democrat colleagues have presented. While I was

Read More

Trump, Tillis Weakness on Insulin Price Tags

During the first presidential debate of 2020, President Donald Trump touted his efforts to curb skyrocketing drug prices and declared that insulin is now “so cheap, it’s like water.” The response on social media was swift, and divided, with some people sharing pharmacy bills showing thousands of dollars they’d spent on insulin, while others boasted of newfound savings.

The next day, a self-described progressive political action committee called Change Now jumped into the fray by releasing an ad that circulated on Facebook attacking Trump and Sen. Thom Tillis (R-N.C.) on this issue.

In the 30-second ad, a North Carolina woman in her 30s explains she was diagnosed with Type 1 diabetes at age 4.

“Donald Trump and Thom Tillis opposed legislation that would lower the price of insulin and other prescription drugs,” she says. “People with diabetes can’t afford to wait for Trump and Tillis to fight for us. … We need affordable insulin now.”

(Posts sharing the quote were flagged as part of Facebook’s efforts to combat false news and misinformation on its news feed. Read more about PolitiFact’s partnership with Facebook.)

In recent years, politicians on both sides of the aisle have committed to addressing the cost of insulin. This election cycle — coinciding with a looming threat to the Affordable Care Act and millions of people losing jobs and employer-sponsored health insurance during the pandemic — the high price of prescription drugs has gained new significance.

Tillis is in one of the most heated Senate races in the country and has been repeatedly criticized by his opponent for receiving more than $400,000 in campaign contributions from the pharmaceutical and health product industries. Across the country, many voters say lowering prescription drug costs should be the top health priority for elected officials.

So, did Trump and Tillis really oppose policies that would accomplish that goal? We decided to take a closer look.

It turns out they’ve both opposed certain pieces of legislation that could have lowered the price of insulin and other prescription drugs, but they’ve also offered alternatives. The question is how aggressive those alternatives are and how many Americans would benefit from them.

Opposing the Strongest Reforms

Change Now pointed to two congressional bills to support the ad’s claim: one opposed by Trump, and the other by Tillis.

The first bill, known as H.R. 3, passed the House in December 2019, largely due to Democratic votes. It contains three main elements: decreasing out-of-pocket costs for people on Medicare, penalizing pharmaceutical companies that raise the price of drugs faster than the rate of inflation and — the most aggressive and controversial feature — allowing the federal government, which administers Medicare, to negotiate the price of certain drugs, including insulin. It also requires manufacturers to offer those agreed-on prices to private insurers, extending the benefits to a wider swath of Americans.

Stacie Dusetzina, an associate professor of health policy at Vanderbilt University School of Medicine, called it “the broadest-reaching policy that has been put forward” on drug pricing.

Read More